ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 240 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PINNACLE ASSOCIATES LTD | 123,196 | $5,683,031 | 0.10% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 67,348 | $3,106,763 | 0.10% |
| MOORE CAPITAL MANAGEMENT, LP | 105,000 | $4,843,650 | 0.08% |
| MARSHALL WACE, LLP | 926,637 | $42,745,765 | 0.08% |
| DUALITY ADVISERS, LP | 14,323 | $660,720 | 0.08% |
| XTX Topco Ltd | 9,349 | $431,269 | 0.08% |
| Caption Management, LLC | 90,000 | $4,151,700 | 0.07% |
| Caption Management, LLC | 90,000 | $4,151,700 | 0.07% |
| PROFUND ADVISORS LLC | 28,706 | $1,324,208 | 0.07% |
| Linden Thomas Advisory Services, LLC | 6,172 | $284,719 | 0.06% |
| FOX RUN MANAGEMENT, L.L.C. | 4,887 | $225,437 | 0.06% |
| FIRST TRUST ADVISORS LP | 1,154,836 | $53,272,584 | 0.06% |
| WS MANAGEMENT LLLP | 15,885 | $732,775 | 0.06% |
| Ergoteles LLC | 26,662 | $1,229,918 | 0.06% |
| Point72 Asset Management, L.P. | 424,874 | $19,599,438 | 0.06% |
| TWO SIGMA ADVISERS, LP | 490,500 | $22,626,765 | 0.06% |
| Engineers Gate Manager LP | 32,926 | $1,518,876 | 0.06% |
| ALGERT GLOBAL LLC | 26,850 | $1,239 | 0.05% |
| AXA S.A. | 345,220 | $15,924,999 | 0.05% |
| Hennion & Walsh Asset Management, Inc. | 18,325 | $845 | 0.05% |
External links
This page lists ULTRAGENYX PHARMACEUTICAL IN's shareholders in Q2 2023. To view ULTRAGENYX PHARMACEUTICAL IN's shareholder history, click here.